GlaxoSmithKline’s new drug to treat Chrohn’s disease has failed in the first of four clinical trials, according to WRAL Tech Wire. The drug, vercirnon, relieved patients’ moderate-to-severe Chrohn’s ...

Coronado Biosciences, a biopharmaceutical company based in Burlington, Mass., has announced that it has enrolled in TRUST-1, phase 2 of its clinical trial of TSO for Chrohn's disease. The clinical ...

A simple vaccine could stop the onset of autoimmune diseases such as rheumatoid arthritis and Chrohn's, say scientists. The potential treatment has proved successful in animal studies and it is hoped ...

Crohn’s disease and ulcerative colitis are both known as inflammatory bowel diseases (IBD), and are the most common. This means they cause chronic inflammation of your digestive tract, usually leading ...

In 2018, Adam, the son of John and Amy Fein, was diagnosed with Chrohn's at the age of 10. He is one of the many reasons the family is asking you to help fight for a cure.

Researchers at the University of Edinburgh have identified chemical changes in patients with the condition, which could hold clues as to how to fight it. These changes in the DNA of people with the ...

The New England Chapter of the Crohn's & Colitis Foundation of America raised $840,000 at a food and wine event on Nov. 6 at the Four Seasons Hotel in Boston. Former New England Patriot Matt Light, ...